Top Research Reports for Amgen, Thermo Fisher & Pepsi
Amgen beat second-quarter estimates for earnings and sales, but price declines and increased competition are hurting sales of some products. PepsiCo shares are up 2% year-to-date, while North American demand stays soft and pricing power moderates; affordability spending and higher input costs pressure margins, with earnings expected to skew toward fourth quarter 2026. A $276.20 million bank’s loan growth is outpacing deposits, raising reliance on costly borrowings.